Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Home
/
About the Reporter
/
Park Pyeongtak
Park Pyeongtak
Reporter
Biowatch Team
With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail
ppt@kormedi.com
Latest Articles
JW Pharmaceutical Expands 'Frenz' Brand Beyond Eye Drops with Launch of 'Eye Crunch' Candy
9/7/2026
Zymfentra U.S. Sales Surge 176% as Celltrion’s Remsima Franchise Eyes 1 Trillion Won Annual Revenue
9/2/2026
Chong Kun Dang Expands 'Modcol' Cold Medicine Lineup with Acetaminophen and Ibuprofen Options
9/2/2026
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
8/29/2026
Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
8/24/2026
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide
8/23/2026
AbTis Wins U.S. Patent Ruling, Safeguarding Core Rights to AbClick Platform
8/21/2026
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
8/21/2026
Previous
2
3
4
5
6
Next